Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression.
Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression.
复制标题
DOI:
10.1002/adma.201300343
复制
发表时间:
2013-07-12
影响因子:
29.4
通讯作者:
Ho, Dean
中科院分区:
文献类型:
--
作者:
Moore, Laura;Chow, Edward Kai-Hua;Osawa, Eiji;Bishop, J. Michael;Ho, Dean
The current clinical standards in cancer chemotherapy are limited by shortcomings such as poor water solubility, short circulation half-life, high toxicity and cellular resistance. Targeted nanoparticle drug delivery systems have the potential to overcome a number of these challenges [1-4]. Nanodiamonds (NDs) have shown great promise in the fields of biomedical imaging and drug delivery and have been functionalized with a variety of small molecule therapeutics, contrast agents, proteins, polymers and nucleic acids [1, 2, 5-16]. Although NDs are both safe [2, 17-20] and effective at delivering contrast agents [2, 15] and chemotherapeutics [2, 9, 19], in vivo tumor localization has been primarily reliant on passive mechanisms. Previous studies have reported the ability to target nanoparticles to specific subpopulations of cells through the covalent attachment of a protein ligand or antibody [9, 21-24]. For this reason we have developed self-assembled nanodiamond-lipid hybrid particles (NDLPs) that harness the potent interaction between the nanodiamond* dean. ho@ ucla. edu. Chow Current Address: Cancer Science Institute of Singapore Department of Pharmacology Yong Loo Lin School of Medicine National University of Singapore Singapore 117599
登录
查看更多内容
影响因子:
4.2
作者:
Nogi, Hiroko;Kobayashi, Tadashi;Uchida, Ken
通讯作者:
Uchida, Ken
DOI:
10.1016/0005-2736(90)90440-y
发表时间:
1990-11-02
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA
影响因子:
--
作者:
BLUME, G;CEVC, G
通讯作者:
CEVC, G
影响因子:
15
作者:
Mochalin, Vadym N.;Gogotsi, Yury
通讯作者:
Gogotsi, Yury
影响因子:
5.7
作者:
Chen, Mark;Zhang, Xue-Qing;Ho, Dean
通讯作者:
Ho, Dean
影响因子:
10.8
作者:
Mohan, Nitin;Chen, Chao-Sheng;Chang, Huan-Cheng
通讯作者:
Chang, Huan-Cheng